Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $16.6700 (-11.14%) ($16.6400 - $16.6700) on Thu. Apr. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.07% (three month average) | RSI | 44 | Latest Price | $16.6700(-11.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -4.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(68%) IWO(62%) IWC(61%) IBUY(60%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.535% in a week (0% probabilities). VIXM(-30%) UUP(-15%) VXX(-10%) TBT(-10%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.535% (StdDev 5.07%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $18.86 | 5 Day Moving Average | $17.85(-6.61%) | 10 Day Moving Average | $18.9(-11.8%) | 20 Day Moving Average | $18.86(-11.61%) | To recent high | -24.5% | To recent low | 18.2% | Market Cap | $1.035b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |